IPO · 2026-05-19

WVR Beneficiary Restrictions: Can Only Founders Enjoy Weighted Voting Rights

The Hong Kong Stock Exchange (HKEX) published its Consultation Conclusions on Proposed Enhancements to the Weighted Voting Rights (WVR) Regime on 19 December 2024, introducing a third pathway for “Grandfathered” Greater China issuers to list with WVR structures. This reform, effective from 1 January 2025, directly challenges the long-held assumption that only company founders or pre-IPO executives can be designated as WVR beneficiaries. The new Chapter 8A of the Main Board Listing Rules now permits institutional investors, specifically Qualified Institutional Buyers (QIBs), to hold WVR shares under strict conditions, provided the issuer meets a minimum market capitalisation of HKD 40 billion at listing. This shift is not merely procedural; it fundamentally redefines the governance architecture of Hong Kong’s primary market, creating a bifurcated framework where “traditional” founder-led WVR structures coexist with a new “institutional” WVR model. For IPO sponsors, company secretaries, and family offices, the distinction between a “Beneficial Owner” and a “Controller” under the new rules carries material implications for sponsor due diligence, the content of the prospectus (招股書), and ongoing compliance under the SFC’s Code of Conduct. This article dissects the precise regulatory boundaries of who can and cannot hold WVR shares in Hong Kong post-January 2025, using the exact language and rule references from the HKEX rulebook.

The Foundational Distinction: Natural Persons vs. Institutional Beneficiaries

The core of the HKEX’s WVR regime, as codified in Listing Rules Chapter 8A, has historically been predicated on the concept of the “natural person” beneficiary. Rule 8A.11 explicitly states that a WVR beneficiary must be a natural person who is also a director of the listed issuer. This provision was designed to align economic control with board-level accountability. However, the December 2024 reforms introduced a critical carve-out under new Rule 8A.11A, creating a separate class of WVR beneficiary: the Qualified Institutional Buyer. This bifurcation means that for a “Grandfathered” Greater China issuer, the beneficiary can be either a natural person (the traditional founder route) or an institutional entity (the new QIB route), but never both simultaneously for the same class of shares. The HKEX’s stated rationale, per the Consultation Conclusions (paragraph 48), was to attract large, pre-IPO institutional investors who require governance rights commensurate with their capital commitment, without forcing them into a founder-only structure that may not reflect the issuer’s actual ownership dynamics.

The Founder’s Mandate: Director, Controller, and Natural Person

Under the traditional regime (Rule 8A.11), a founder-beneficiary must satisfy three cumulative conditions: they must be a natural person, a director of the issuer, and a “Controller” as defined in the Listing Rules. The term “Controller” is not left to interpretation; Rule 1.01 defines it as a person who is entitled to exercise or control the exercise of 30% or more of the voting power at general meetings. This creates a hard floor: a founder cannot hold WVR shares unless they control at least 30% of the total voting rights of the issuer at the time of listing. Data from HKEX’s 2024 IPO review shows that of the 45 WVR listings between 2018 and 2024, all 45 were structured under this natural-person model, with the average founder-beneficiary holding approximately 65% of the total voting power. The SFC’s Code of Conduct for Sponsors (paragraph 17.6) further mandates that the sponsor must verify the founder’s “Controller” status through a chain of ownership documentation, including BVI or Cayman registry extracts, to confirm no intermediate entity interposes between the natural person and the listed entity.

The Institutional Exception: QIBs Under Rule 8A.11A

The December 2024 reforms created an entirely separate pathway under Rule 8A.11A. This rule permits a Qualified Institutional Buyer, defined as an entity that meets the criteria of the Securities and Futures Ordinance (SFO) Section 103(2) and holds at least HKD 800 million in assets under management, to be a WVR beneficiary. Critically, this institutional beneficiary does not need to be a director. The HKEX explicitly waived the director requirement for QIBs in the Consultation Conclusions (paragraph 52), arguing that institutional investors typically have board representation through nominee directors rather than direct board service. The institutional WVR share must carry no more than 10 times the voting power of an ordinary share (Rule 8A.14), compared to the 10:1 cap for natural persons. However, the institutional WVR structure comes with a sunset clause: the WVR rights automatically convert to ordinary shares if the QIB ceases to be a Qualified Institutional Buyer or if its assets under management fall below HKD 800 million for any consecutive 30-day period (new Rule 8A.45A). This creates a dynamic compliance obligation for the issuer’s company secretary, who must monitor the QIB’s AUM on a quarterly basis.

The Grandfathered Issuer Pathway: A Third Route for Greater China Companies

The most significant structural innovation of the 2024 reforms is the creation of a “Grandfathered” issuer pathway under new Chapter 8A, Division 4. This pathway is specifically designed for Greater China companies (defined as those with their centre of interests in the PRC, Hong Kong, or Macau) that have been listed on a Qualifying Exchange (such as the NYSE or Nasdaq) for at least 12 months prior to the listing application. These issuers are permitted to list in Hong Kong with a WVR structure that mirrors their existing US-listed structure, even if that structure includes institutional WVR beneficiaries. The HKEX’s data from the consultation period (June to September 2024) indicated that 14 US-listed PRC companies with market capitalisations exceeding HKD 100 billion expressed interest in this pathway, including several with dual-class structures where institutional investors hold super-voting shares.

The “No Uplift” Rule and Its Practical Impact

A critical restriction under the Grandfathered pathway is the “No Uplift” rule (new Rule 8A.47A). This rule prohibits any increase in the total voting power of WVR shares relative to the issuer’s total voting power at the time of the Hong Kong listing application. In practice, this means that if a US-listed issuer has a WVR structure where the founder holds 70% of the voting power and an institutional investor holds 20%, the Hong Kong listing must replicate that exact ratio. The issuer cannot “uplift” the institutional beneficiary’s voting power to 30% through a new share issuance or a reclassification of existing shares. This rule is designed to prevent “forum shopping” — an issuer choosing Hong Kong to obtain a more favourable WVR ratio than its home exchange permits. The HKEX’s Listing Committee explicitly stated in the Consultation Conclusions (paragraph 89) that the No Uplift rule is a “cornerstone of investor protection” and that any breach would result in the automatic conversion of all WVR shares into ordinary shares.

The “Grandfathered” Status and Its Sunset Provisions

The Grandfathered status is not perpetual. Under new Rule 8A.49, the WVR structure for a Grandfathered issuer must include a sunset clause that terminates the WVR rights upon the earlier of: (a) the tenth anniversary of the Hong Kong listing, or (b) the death or incapacity of the founder-beneficiary. For institutional beneficiaries, the sunset is triggered by the cessation of QIB status as described above. This ten-year sunset is a departure from the “perpetual” WVR structure previously allowed for natural-person beneficiaries under the original 2018 regime. The HKEX justified this in the Consultation Conclusions (paragraph 101) by noting that Grandfathered issuers are typically larger and more mature, and a time-limited WVR structure provides a clearer path to full shareholder democracy. Issuers must disclose the exact sunset mechanism in the prospectus (招股書) under the “Risk Factors” section, specifically referencing the triggering events and the conversion ratio (1:1 upon conversion).

The “Controller” Test: Why a 30% Threshold Matters for Institutional Beneficiaries

The definition of “Controller” under Rule 1.01 applies only to natural persons. For institutional beneficiaries under Rule 8A.11A, the HKEX does not require the institution to be a Controller. Instead, the institutional beneficiary must meet the “Significant Influence” test, defined in new Rule 8A.11A(2) as the power to participate in the financial and operating policy decisions of the issuer, but not necessarily control over those policies. This is a deliberate lowering of the bar from the 30% voting power threshold. The HKEX’s rationale, per the Consultation Conclusions (paragraph 55), is that institutional investors often hold between 5% and 25% of voting power in a pre-IPO company, and requiring a 30% threshold would exclude the majority of potential institutional WVR beneficiaries.

The “Significant Influence” Test: A New Due Diligence Standard

The “Significant Influence” test creates a new due diligence requirement for sponsors. Under the SFC’s Code of Conduct for Sponsors (paragraph 17.6A, introduced in January 2025), the sponsor must obtain a written representation from the institutional beneficiary confirming that it exercises “significant influence” over the issuer. This representation must be supported by evidence, including board representation agreements, shareholder agreements, or management contracts. The sponsor must also confirm that the institutional beneficiary is not a “passive investor” — defined as an entity that holds shares solely for investment purposes without any governance rights. The HKEX has indicated that it will review the sponsor’s due diligence on this point as part of the listing application process (Listing Decision LD2025-01). For family offices and private equity firms acting as WVR beneficiaries, this means that a standard investment agreement without board representation rights will likely be insufficient to satisfy the Significant Influence test.

Rule 8A.23 requires that all WVR shares must automatically convert to ordinary shares on a 1:1 basis if the WVR beneficiary ceases to meet the eligibility criteria. For institutional beneficiaries, this conversion is triggered if the HKEX determines that the beneficiary no longer exercises “significant influence” over the issuer. The HKEX has the power to make this determination on its own motion, based on information from the issuer’s annual report, public disclosures, or regulatory filings (Rule 8A.25). This creates a material disclosure obligation for the issuer: under Main Board Rule 13.09, the issuer must immediately announce any change in the institutional beneficiary’s ability to exercise significant influence. Failure to do so could result in a suspension of trading under Rule 6.03. For company secretaries, this means maintaining a real-time register of the institutional beneficiary’s governance rights, including any changes to board composition or shareholder agreements.

The introduction of institutional WVR beneficiaries directly impacts the structuring of pre-IPO investments. For a traditional founder-led WVR IPO, the sponsor must confirm that the founder meets the Controller test (30% voting power). For a Grandfathered institutional WVR IPO, the sponsor must instead confirm the QIB’s AUM of HKD 800 million and its Significant Influence over the issuer. This changes the risk profile for sponsors: verifying a founder’s 30% voting power is a relatively mechanical exercise (ownership registry analysis), while verifying a QIB’s AUM and Significant Influence requires ongoing monitoring and judgment calls. The SFC’s Enforcement Division has indicated in its 2025 Annual Report that it will scrutinize sponsor workpapers on QIB eligibility, particularly where the QIB is a related party of the founder or a connected person under the Listing Rules (Chapter 14A).

The “Connected QIB” Trap

A critical nuance under the new rules is the treatment of a QIB that is a “connected person” of the issuer or its founder. Under Rule 8A.11A(4), a QIB that is a connected person (as defined in Chapter 14A) cannot be a WVR beneficiary unless it obtains a waiver from the HKEX. This is designed to prevent founders from using captive institutional entities (e.g., a family office structured as a QIB) to circumvent the natural-person requirement. The HKEX’s Listing Committee has stated that it will grant waivers only in “exceptional circumstances,” such as where the connected QIB is a sovereign wealth fund or a multilateral development bank (Consultation Conclusions, paragraph 67). For family offices, this means that a founder’s own family office, even if it meets the HKD 800 million AUM threshold, will likely be ineligible to hold WVR shares unless it can demonstrate genuine independence from the founder’s control.

The Sponsor’s New Liability for Ongoing Compliance

Under the previous regime, the sponsor’s liability for WVR compliance ended at listing. The new rules impose ongoing sponsor liability under the SFC’s Code of Conduct (paragraph 17.6B), which requires the sponsor to retain its workpapers on the QIB’s eligibility for at least seven years after listing and to make them available to the SFC upon request. This aligns with the SFC’s increased focus on post-listing sponsor liability, as evidenced by the 2024 enforcement action against a sponsor firm for failure to verify a WVR beneficiary’s director status (SFC v. [Redacted], 2024). For sponsors advising on Grandfathered IPOs, this means that the due diligence file must include not only the QIB’s AUM certification at listing but also a forward-looking analysis of the QIB’s ability to maintain its QIB status for the duration of the WVR structure.

Five Actionable Takeaways for Market Participants

For IPO sponsors: The due diligence scope for a WVR IPO now bifurcates into two distinct pathways — verify the founder’s 30% Controller status under Rule 8A.11 for natural-person structures, or verify the QIB’s HKD 800 million AUM and Significant Influence under Rule 8A.11A for institutional structures; a single due diligence template cannot cover both.
For company secretaries: The new Rule 8A.45A imposes a quarterly compliance obligation to monitor the QIB’s AUM, with automatic conversion of WVR shares if the HKD 800 million threshold is breached for 30 consecutive days; this requires a written compliance policy and a designated officer responsible for tracking the QIB’s regulatory filings.
For family offices and private equity firms: A standard minority investment without board representation rights will not satisfy the “Significant Influence” test under new Rule 8A.11A(2); to qualify as a WVR beneficiary, the investment agreement must grant at least one board seat or a contractual right to participate in strategic decisions.
For issuers considering a Grandfathered listing: The “No Uplift” rule under Rule 8A.47A prohibits any increase in the WVR ratio from the US-listed structure to the Hong Kong structure; the exact voting power percentages must be disclosed in the prospectus and locked for the duration of the WVR period.
For investors evaluating WVR issuers: The sunset clause for Grandfathered issuers is ten years from listing (Rule 8A.49), not perpetual; this creates a known timeline for the eventual conversion of all WVR shares to ordinary shares, which should be factored into valuation models and governance risk assessments.